Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022
Thu, March 10, 2022
Wed, March 9, 2022
Tue, March 8, 2022
Mon, March 7, 2022

Kemp Dolliver Initiated (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-20-on-mar-10th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kemp Dolliver of Brookline Capital, Initiated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $20 on, Mar 10th, 2022.

Kemp has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Kemp's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kemp


  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $18 on, Thursday, March 3rd, 2022

Publication Contributing Sources